Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
about
Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patients.Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience.Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC).Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapyQuality of life study following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei including redo proceduresSurvival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin.Current status and future directions: management of colon cancer with peritoneal dissemination.Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C.Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastasesIntraperitoneal chemotherapy: rationale, applications, and limitations.Impact of Major Complications on Patients' Quality of Life After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Long-term Quality of Life After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei: A Prospective Longitudinal Study.Quality-of-Life Evaluation After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.Prospective Quality of Life Study for Colorectal Cancer Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk?
P2860
Q26768306-22C6A6FF-6D0F-4A7B-8B30-EF16A20199BDQ34616030-CB078E8B-E5AA-4F25-AF20-5C016E6DAEDEQ36103736-DBC74FE7-752F-48AF-BAA6-A54B972DD028Q36890780-CE6F7ADE-B159-412A-B34C-63EF506ECEE0Q37090867-6CE5C0F1-D909-44D3-9F4A-3CE68EDF37E8Q37100974-624D908B-227B-42AD-A91C-783DD94CBE4BQ37158542-918185F5-2CAD-4728-B7F8-7B7443CFE572Q37298660-8ED641CE-B244-41B6-A612-F12F39F0B9ADQ37770974-B915A07B-2A38-452C-8A76-CBE78055D16DQ38085569-F90A0493-B825-4432-929C-E58552D126BCQ38156120-B43B15A6-21EC-4B67-89FA-2A8518741FC8Q39838681-A0D2A261-4B75-44EA-AF4A-754D4F0B48BEQ47192896-3635C4C4-B3A6-4D13-9956-59E0CE5240A3Q47657613-9F83B07E-60B3-47FE-B4D4-B74DD694FC4DQ47789478-6B8F9EEF-66C5-4265-8BCA-40F8DAD88BF6Q48229364-52071C61-A7B4-4A3D-A23C-960390840E39
P2860
Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Toxicity and quality of life a ...... intraperitoneal chemotherapy.
@ast
Toxicity and quality of life a ...... intraperitoneal chemotherapy.
@en
type
label
Toxicity and quality of life a ...... intraperitoneal chemotherapy.
@ast
Toxicity and quality of life a ...... intraperitoneal chemotherapy.
@en
prefLabel
Toxicity and quality of life a ...... intraperitoneal chemotherapy.
@ast
Toxicity and quality of life a ...... intraperitoneal chemotherapy.
@en
P2093
P1476
Toxicity and quality of life a ...... intraperitoneal chemotherapy.
@en
P2093
Amy Knutsen
Edward Greeno
Todd M Tuttle
P2888
P304
P356
10.1245/S10434-006-9186-6
P577
2006-10-01T00:00:00Z
P6179
1028965641